6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Scott H. Kollins; Andrew J. Cutler; Sohail Khattak; Margaret D. Weiss; Graeme Donnelly; Joseph L. Reiz

doi:10.1016/j.jaac.2016.09.362

6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.362 ◽

2016 ◽

Vol 55 (10) ◽

pp. S217-S218 ◽

Cited By ~ 1

Author(s):

Scott H. Kollins ◽

Andrew J. Cutler ◽

Sohail Khattak ◽

Margaret D. Weiss ◽

Graeme Donnelly ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Multicenter Study ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Release Formulation ◽

Double Blind Placebo ◽

Extended Release Formulation ◽

Hyperactivity Disorder

Download Full-text

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.12m07767 ◽

2012 ◽

Vol 73 (12) ◽

pp. 1517-1523 ◽

Cited By ~ 18

Author(s):

Iris Manor ◽

Rachel Ben-Hayun ◽

Judith Aharon-Peretz ◽

Dana Salomy ◽

Abraham Weizman ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Multicenter Study ◽

Attention Deficit ◽

Extended Release ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Download Full-text

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2019.0085 ◽

2020 ◽

Vol 30 (2) ◽

pp. 58-68

Author(s):

Ann C. Childress ◽

Scott H. Kollins ◽

Henry C. Foehl ◽

Jeffrey H. Newcorn ◽

Greg Mattingly ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Dose Titration ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Flexible Dose ◽

Titration Study

Download Full-text

Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12913 ◽

2019 ◽

Vol 73 (11) ◽

pp. 690-696 ◽

Cited By ~ 5

Author(s):

Sara Dehbozorghi ◽

Sayna Bagheri ◽

Kamyar Moradi ◽

Kamyar Shokraee ◽

Mohammad‐Reza Mohammadi ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

European Psychiatry ◽

10.1016/s0924-9338(14)78034-4 ◽

2014 ◽

Vol 29 ◽

pp. 1 ◽

Cited By ~ 3

Author(s):

J. Newcorn ◽

V. Harpin ◽

M. Huss ◽

M. Johnson ◽

J.A. Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Hyperactivity Disorder ◽

Term Maintenance

Download Full-text

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

The World Journal of Biological Psychiatry ◽

10.3109/15622975.2011.600333 ◽

2011 ◽

Vol 14 (4) ◽

pp. 268-281 ◽

Cited By ~ 9

Author(s):

Miguel Casas ◽

Michael Rösler ◽

J. J. Sandra Kooij ◽

Ylva Ginsberg ◽

Josep Antoni Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Fixed Dose ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Study

Download Full-text

6.22 A Double-Blind, Placebo-Controlled, Dose-Ranging Study of Extended-Release Viloxazine (SPN-812 ER) in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.367 ◽

2017 ◽

Vol 56 (10) ◽

pp. S283-S284

Author(s):

Janet K. Johnson ◽

Keith Saylor ◽

Scott T. Brittain ◽

Gabriela Tulloch ◽

Tesfaye Liranso

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Ranging

Download Full-text

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Behavioral and Brain Functions ◽

10.1186/1744-9081-6-34 ◽

2010 ◽

Vol 6 (1) ◽

pp. 34 ◽

Cited By ~ 86

Author(s):

Timothy Wigal ◽

Matthew Brams ◽

Maria Gasior ◽

Joseph Gao ◽

Liza Squires ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Crossover Study ◽

Attention Deficit ◽

Environment Design ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Workplace Environment ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text